课题基金 / 基金详情

STUDIES OF DRUG-INDUCED CANCER AND MULTIPLE PRIMARY CANCERS

STUDIES OF DRUG-INDUCED CANCER AND MULTIPLE PRIMARY CANCERS
药物诱发癌症和多发性原发性癌症的研究
批准号:
3838359
负责人:
J D BOICE
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

J D BOICE的其他基金

相似基金

相关文献

中文摘要
翻译
对药物治疗的后遗症进行研究,特别是 强调用于治疗的药物的致癌潜力 布景。癌症化疗药物的研究是合乎逻辑的 延长该处涉及第二次癌症的活动 首次接受放射治疗,因为许多癌症患者暴露在 两种治疗方式。偶尔,也会有学习的机会 其他与治疗无关的特殊利益药物。来源: 人口包括以人口为基础报告的癌症患者 癌症登记(特别是监测、流行病学和完 结果计划)、随机临床试验和接受治疗的人 主要机构。有关协作项目的其他详细信息,请参阅 在项目编号中找到Z01CP04412-16EEB,“致癌效应” 治疗药物“和项目编号Z01CP04410-16EEB,”研究 癌症高危人群。“ 用于乳腺癌的烷化剂与显著相关 患急性白血病的风险很高。马法兰被发现是一种有效的 白血病原,以及较小程度的环磷酰胺。全身用药 治疗与放射治疗相结合似乎增加了罹患 白血病。相比之下,慢性淋巴细胞白血病的化疗是 与过多的第二次癌症无关。接受放射治疗 乳腺癌与对侧乳房的轻微增加有关。 癌症,暴露在45岁以下的女性中才明显。Phenobar- BITAL被发现可以显著降低膀胱癌的风险 癫痫患者。接受视网膜母细胞瘤治疗的儿童被发现在 非常高的风险,在未到 40年,尤其是那些患有双侧疾病的人。进一步放射治疗 增加了患第二次癌症的风险,尤其是骨肉瘤。 儿童癌症的放射治疗与甲状腺的高风险有关。 癌症。放射性碘在甲状腺癌治疗中的应用 与第二次癌症的风险无关。
英文摘要
Studies of the late effects of drug therapy are conducted, with special emphasis on the carcinogenic potential of drugs used in a therapeutic setting. Studies of cancer chemotherapeutic agents are a logical extension to the Branch's activities involving second cancer following radiation for a first primary, since many cancer patients are exposed to both treatment modalities. Occasionally, opportunities arise to study other drugs of special interest unrelated to treatment. Sources of populations have included cancer patients reported to population-based cancer registries (particularly the Surveillance, Epidemiologic, and End Results program), randomized clinical trials, and persons treated at major institutions. Additional details on collaborative projects can be found in Project No. Z01CP04412-16 EEB, "Carcinogenic Effects of Therapeutic Drugs" and Project No. Z01CP04410-16 EEB, "Studies of Persons at High Risk of Cancer." Alkylating agents given for breast cancer were linked to significantly high risks of acute leukemia. Melphalan was found to be a potent leukemogen, and to a lesser extent cyclophosphamide. Systemic drug therapy combined with radiation treatment appeared to enhance the risk of leukemia. In contrast, chemotherapy for chronic lymphocytic leukemia was not associated with an excess of second cancer. Radiation treatments for breast cancer were linked to a slight increase in contralateral breast cancer, apparent only among women under age 45 when exposed. Phenobar- bital was found to significantly reduce bladder cancer risk among epileptics. Children treated for retinoblastoma were found to be at very high risk of dying from a second cancer before reaching the age of 40 years, especially those with bilateral disease. Radiotherapy further increased the risk of second cancers, especially osteosarcomas. Radiotherapy for childhood cancer was linked to a high risk of thyroid cancer. Radioactive iodine in the treatment of thyroid cancer appeared unrelated to the risk of second cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDIES OF RADIATION-INDUCED CANCER
STUDIES OF RADIATION-INDUCED CANCER
STUDIES OF DRUG-INDUCED CANCER AND MULTIPLE PRIMARY CANCERS
STUDIES OF RADIATION-INDUCED CANCER
海外基金